In our study, we found that the ATG5 mutation (coupled with LOH of the other allele) was accompanied by the presence of clonal mutations in MYCN and MAP2K4 in both HCC samples but these were absent from the FNH. Here, ATG5 is linked to hepatocellular carcinoma.